Relationships of serum haptoglobin concentration with HbA1c and glycated albumin concentrations in Japanese type 2 diabetic patients
-
Kaoru Suzuki
Abstract
Background: The stable fractions of glycated hemoglobin (Hb), particularly HbA1c, and glycated albumin (GA) were measured to monitor chronic glycemic control. Haptoglobin (Hp) is a Hb-binding protein, which plays a major role in preventing free Hb-induced tissue oxidative damage. The aim of this study was to clarify the relationships of serum Hp concentration with HbA1c and GA concentrations.
Methods: A cross-sectional study to determine the relationship of serum Hp concentration with GA and HbA1c concentrations was conducted. The subjects were 125 Japanese type 2 diabetic patients with stable HbA1c levels for more than 3 consecutive months. Patients with altered albumin and red blood cell turnover, which are observed in those with chronic renal failure, liver cirrhosis, and anemia among others, were excluded from the study.
Results: Serum Hp concentration positively correlated with HbA1c concentration (r=0.30, p<0.001), but not with GA concentration (r=0.15, p=0.10). There was a weak inverse correlation between serum Hp concentration and GA/HbA1c ratio (r=−0.19, p=0.03). Moreover, GA /HbA1c ratio inversely correlated with body mass index (BMI) (r=−0.31, p<0.001). In contrast, there was no significant correlation between Hb concentration and HbA1c (r=0.01, p=0.88) or GA (r=0.12, p=0.21) concentrations. We also analyzed the correlation of serum Hp concentration with GA and HbA1c concentrations in patients with the Hp 2-1 and Hp 2-2 genotypes, separately. Hp concentration positively correlated with HbA1c concentration in patients with the Hp 2-1 (r=0.32, p=0.03) and Hp 2-2 (r=0.29, p=0.02) phenotypes. Multiple regression analysis revealed that the observed correlation between Hp and HbA1c concentrations was significant after adjustment for age, gender, and BMI. In contrast, there was no significant correlation between GA and Hp concentrations in patients with either phenotype. Then, we analyzed how Hp concentration affects GA/HbA1c ratio in patients with these Hp phenotypes. There was an inverse correlation between Hp concentration and GA/HbA1c ratio in patients with Hp 2-1 (r=−0.44, p=0.003), but not in those with Hp 2-2 (r=−0.03, p=0.75). Multiple regression analysis revealed that the inverse correlation between Hp concentration and GA/HbA1c ratio in patients with Hp 2-1 was independent of age, gender, and BMI.
Conclusions: Hp phenotype and concentration should be considered in interpreting HbA1c and GA levels as glycemic control indicators in diabetic patients. We suggest that in type 2 diabetic patients with Hp 2-1 and high Hp concentrations, HbA1c level may be overestimated relative to GA level.
Clin Chem Lab Med 2009;47:70–4.
©2009 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Reviews
- Molecular markers detecting circulating melanoma cells by reverse transcription polymerase chain reaction: methodological pitfalls and clinical relevance
- HIV-GB virus C co-infection: an overview
- Genetics and Molecular Diagnostics
- Relationships between C-reactive protein concentration and genotype in healthy volunteers
- SYBR Green-based real-time PCR assay for detection of VKORC1 and CYP2C9 polymorphisms that modulate warfarin dose requirement
- Functional polymorphisms in ACE and CYP11B2 genes and atrial fibrillation in patients with hypertensive heart disease
- No effect of MDR1 C3435T polymorphism on oral pharmacokinetics of telmisartan in 19 healthy Chinese male subjects
- A novel large deletion and three polymorphisms in the FECH gene associated with erythropoietic protoporphyria
- Aging and endothelial progenitor cell telomere length in healthy men
- Gln222Arg (A2317G) polymorphism in the deoxyribonuclease I gene exhibits ethnic and functional differences
- Mutation screening of the medium-chain acyl-CoA dehydrogenase (MCAD) and the ornithine transcarbamylase (OTC) genes by multiplex PCR amplification and sequencing
- General Clinical Chemistry and Laboratory Medicine
- Nitrated apolipoprotein A-I, a potential new cardiovascular marker, is markedly increased in low high-density lipoprotein cholesterol subjects
- Relationships of serum haptoglobin concentration with HbA1c and glycated albumin concentrations in Japanese type 2 diabetic patients
- Multi-elements (aluminium, copper, magnesium, manganese, selenium and zinc) determination in serum by dynamic reaction cell-inductively coupled plasma-mass spectrometry
- Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients
- Validation and Outcome Studies
- Validation for quantification of immunoglobulins by Fourier transform infrared spectrometry
- Albumin-based or albumin-linked calibrators cause a positive bias in serum proteins assayed by the biuret method
- Current practices in antinuclear antibody testing: results from the Belgian External Quality Assessment Scheme
- Verification of the analytical range of a new reagent for full-range C-reactive protein determination
- Measurement uncertainty in manual differential leukocyte counting
- Letters to the Editor
- Falsely elevated carbohydrate antigen 19-9 level due to heterophilic antibody interference but not rheumatoid factor: a case report
- An unusual interference in parathormone assay caused by anti-goat IgG: a case report
Articles in the same Issue
- Reviews
- Molecular markers detecting circulating melanoma cells by reverse transcription polymerase chain reaction: methodological pitfalls and clinical relevance
- HIV-GB virus C co-infection: an overview
- Genetics and Molecular Diagnostics
- Relationships between C-reactive protein concentration and genotype in healthy volunteers
- SYBR Green-based real-time PCR assay for detection of VKORC1 and CYP2C9 polymorphisms that modulate warfarin dose requirement
- Functional polymorphisms in ACE and CYP11B2 genes and atrial fibrillation in patients with hypertensive heart disease
- No effect of MDR1 C3435T polymorphism on oral pharmacokinetics of telmisartan in 19 healthy Chinese male subjects
- A novel large deletion and three polymorphisms in the FECH gene associated with erythropoietic protoporphyria
- Aging and endothelial progenitor cell telomere length in healthy men
- Gln222Arg (A2317G) polymorphism in the deoxyribonuclease I gene exhibits ethnic and functional differences
- Mutation screening of the medium-chain acyl-CoA dehydrogenase (MCAD) and the ornithine transcarbamylase (OTC) genes by multiplex PCR amplification and sequencing
- General Clinical Chemistry and Laboratory Medicine
- Nitrated apolipoprotein A-I, a potential new cardiovascular marker, is markedly increased in low high-density lipoprotein cholesterol subjects
- Relationships of serum haptoglobin concentration with HbA1c and glycated albumin concentrations in Japanese type 2 diabetic patients
- Multi-elements (aluminium, copper, magnesium, manganese, selenium and zinc) determination in serum by dynamic reaction cell-inductively coupled plasma-mass spectrometry
- Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients
- Validation and Outcome Studies
- Validation for quantification of immunoglobulins by Fourier transform infrared spectrometry
- Albumin-based or albumin-linked calibrators cause a positive bias in serum proteins assayed by the biuret method
- Current practices in antinuclear antibody testing: results from the Belgian External Quality Assessment Scheme
- Verification of the analytical range of a new reagent for full-range C-reactive protein determination
- Measurement uncertainty in manual differential leukocyte counting
- Letters to the Editor
- Falsely elevated carbohydrate antigen 19-9 level due to heterophilic antibody interference but not rheumatoid factor: a case report
- An unusual interference in parathormone assay caused by anti-goat IgG: a case report
